Does anaphylactoid reaction to one immunotherapy agent exclude the possibility of using other immunotherapy agents?   

Regarding PD1 inhbitors cross reactivity,  I have never heard of patients having grade 3+ anaphylaxis with these agents. I have had several patients have infusion related reactions or delayed sensitivities from them. We, however, just re-challenge by slowing infusions rates, administering Benad...